CIMdata PLM Industry Summary Online Archive
5 November 2008
Implementation Investments
InnoCielo Meridian Enterprise and FDA Module Selected By Genzyme
BlueCielo ECM Solutions announced that Genzyme Corporation, one of the world’s foremost biotechnology companies, has chosen BlueCielo to implement and validate its innovative ECM solution, InnoCielo Meridian Enterprise and the FDA Module, at four of the company’s worldwide locations. These locations include Framingham, MA, USA; Suffolk, United Kingdom; Waterford, Ireland and Geel, Belgium. Genzyme continues to demonstrate its leadership by implementing sophisticated technology that will take it to new levels of efficiency and compliance. The FDA Module provides the technical controls related to compliance with 21 CFR Part 11 for their engineering drawings.
With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. Founded in Boston in 1981, Genzyme has grown from a small start-up to a diversified enterprise with 2007 revenues of $3.8 billion and 10,000 employees in locations spanning the globe.
"We continue to see a rapid adoption of the InnoCielo product suite in the biotechnology and pharmaceutical sectors,” says Martijn Janmaat, BlueCielo’s CEO. “Genzyme is a great example of the growing number of global life sciences companies that are bringing products to market faster by optimizing their processes in managing their critical engineering content. With efficient validation processes and the availability of accurate engineering information to the relevant people throughout the enterprise, companies are now much better able to manage and share all required good manufacturing practices (GMP) documentation and comply with the FDA's 21 CFR Part 11 regulation much more easily."
Become a member of the CIMdata PLM Community to receive your daily PLM news and much more.
Tell us what you think of the CIMdata Newsletter. Send your feedback.
CIMdata is committed to your privacy. Your personal information will never be sold or shared outside of CIMdata without your express permission.